The development and production of effective pharmaceuticals often hinge on the intricate chemistry of their constituent parts. In the case of Rivastigmine, a significant medication for cognitive impairment, the intermediate 3-[1-(Dimethylamino)ethyl]phenol (CAS 105601-04-5) plays a pivotal role. Its unique chemical structure and reactivity are instrumental in the synthesis pathway that leads to the final active pharmaceutical ingredient (API). Understanding this chemistry is key for manufacturers aiming for precision and efficiency in their production processes.

3-[1-(Dimethylamino)ethyl]phenol, with its molecular formula C10H15NO and molecular weight of 165.23 g/mol, is a molecule characterized by both a phenolic hydroxyl group and a tertiary amine. These functional groups are critical for its involvement in the chemical reactions that form Rivastigmine. The precise stereochemistry, if relevant for the specific synthetic route, is also a consideration for advanced organic synthesis. The physical form, often a pale brown solid, and its solubility profile are practical aspects that influence laboratory handling and industrial scale-up, making it a key component for pharmaceutical intermediate suppliers.

The reliable supply of 3-[1-(Dimethylamino)ethyl]phenol is a concern for many in the pharmaceutical industry. Manufacturers often look to source this compound from established regions like China, where a robust chemical manufacturing sector exists. When companies search for 'buy 3-[1-(Dimethylamino)ethyl]phenol online', they are seeking not just a product, but assurance of quality and timely delivery. NINGBO INNO PHARMCHEM CO., LTD. is positioned as a manufacturer that can fulfill these needs, providing a dependable source of this crucial intermediate.

The synthesis of pharmaceuticals is a testament to the power of precise chemical engineering. 3-[1-(Dimethylamino)ethyl]phenol exemplifies how a single intermediate can be foundational to the production of a complex and medically important drug. For pharmaceutical companies, securing a stable and high-quality supply of this compound is essential for maintaining production schedules and ensuring the availability of Rivastigmine to patients worldwide. The expertise of pharmaceutical intermediate suppliers in China is invaluable in this regard.